Shiro Ikegami

Oncogene Amplification in Growth Factor Signaling Pathways Renders Cancers Dependent on Membrane Lipid Remodeling

Junfeng Bi, Taka-Aki Ichu, Ciro Zanca et al. · Cell Metabolism · 2019 · 224 citations · Full text

Cancer Research, Oncogene Amplification, Oncogenic Agent +10

Muscle weakness, hyperactivity, and impairment in fear conditioning in tau-deficient mice

Shiro Ikegami · Neuroscience Letters · 2000 · 217 citations

Knockout Mouse, Muscle Weakness, Physiology +4

mTORC2 Regulates Amino Acid Metabolism in Cancer by Phosphorylation of the Cystine-Glutamate Antiporter xCT

Yuchao Gu, Claudio P. Albuquerque, Daniel Braas et al. · Molecular Cell · 2017 · 204 citations · Full text

Biochemistry, Oncogenic Agent, Medicine +7

EGFR Mutation Promotes Glioblastoma through Epigenome and Transcription Factor Network Remodeling

Feng Liu, Gary C. Hon, Genaro R. Villa et al. · Molecular Cell · 2015 · 182 citations · Full text

Neuro-oncology, Glioma, Cancer Genomics +5

Efficient Baylis–Hillman reactions promoted by mild cooperative catalysts and their application to catalytic asymmetric synthesis

Yoichi M. A. Yamada, Shiro Ikegami · Tetrahedron Letters · 2000 · 170 citations

Chemical Engineering, Catalytic Asymmetric Synthesis, Engineering +8